2019 annual financial data

Senti Biosciences Holdings 2019 Operating margin

Senti Biosciences Holdings 2019 operating margin with verified reported values.

Direct answer

Operating margin was -25,625.88%.

Operating income was -21,782,000 USD and net income was -21,157,000 USD.
Operating cash flow was -18,378,000 USD.

Get free Senti Biosciences Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
85,000 USD
Operating income
-21,782,000 USD
Net income
-21,157,000 USD
Operating cash flow
-18,378,000 USD